JAVIER CALLEJA-CONDE

Dr. JAVIER CALLEJA-CONDE

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2020 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
JMJose A. Morales-García
Jose A. Morales-García
JCJAVIER CALLEJA-CONDE
JAVIER CALLEJA-CONDE
JLJosé Antonio López-Moreno
José Antonio López-Moreno
SASandra Alonso-Gil
Sandra Alonso-Gil
MSMarina Sanz-SanCristobal
Marina Sanz-SanCristobal
APAna Perez-Castillo
Ana Perez-Castillo
N,N-dimethyltryptamine (DMT) is a component of the ayahuasca brew traditionally used for ritual and therapeutic purposes across several South American countries. Here, we have examined, in vitro and vivo, the potential neurogenic effect of DMT. Our results demonstrate that DMT administration activates the main adult neurogenic niche, the subgranular zone of the dentate gyrus of the hippocampus, promoting newly generated neurons in the granular zone. Moreover, these mice performed better, compared to control non-treated animals, in memory tests, which suggest a functional relevance for the DMT-induced new production of neurons in the hippocampus. Interestingly, the neurogenic effect of DMT appears to involve signaling via sigma-1 receptor (S1R) activation since S1R antagonist blocked the neurogenic effect. Taken together, our results demonstrate that DMT treatment activates the subgranular neurogenic niche regulating the proliferation of neural stem cells, the migration of neuroblasts, and promoting the generation of new neurons in the hippocampus, therefore enhancing adult neurogenesis and improving spatial learning and memory tasks.

21 January 2015 in Addiction Biology
Verified
Journal Article
Closed access
PDF file
KBKora‐Mareen Bühler
Kora‐Mareen Bühler
EDElena Giné Dominguez
Elena Giné Dominguez
Víctor Echeverry-AlzateVíctor Echeverry-Alzate
Víctor Echeverry-Alzate
JCJAVIER CALLEJA-CONDE
JAVIER CALLEJA-CONDE
FFFernando Rodriguez de Fonseca
Fernando Rodriguez de Fonseca
JLJosé Antonio López-Moreno
José Antonio López-Moreno

13 September 2015 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
JLJosé Antonio López-Moreno
José Antonio López-Moreno
MMMiguel Marcos
Miguel Marcos
JCJAVIER CALLEJA-CONDE
JAVIER CALLEJA-CONDE
Víctor Echeverry-AlzateVíctor Echeverry-Alzate
Víctor Echeverry-Alzate
KBKora M. Bühler
Kora M. Bühler
EDElena Giné Dominguez
Elena Giné Dominguez

Verified
Journal Article
Open access
PDF file
JCJAVIER CALLEJA-CONDE
JAVIER CALLEJA-CONDE
Víctor Echeverry-AlzateVíctor Echeverry-Alzate
Víctor Echeverry-Alzate
KBKora-Mareen Bühler
Kora-Mareen Bühler
PDPedro Durán-González
Pedro Durán-González
JMJose A. Morales-García
Jose A. Morales-García
JLJosé Antonio López-Moreno
José Antonio López-Moreno
The human gut is the largest organ with immune function in our body, responsible for regulating the homeostasis of the intestinal barrier. A diverse, complex and dynamic population of microorganisms, called microbiota, which exert a significant impact on the host during homeostasis and disease, supports this role. In fact, intestinal bacteria maintain immune and metabolic homeostasis, protecting our organism against pathogens. The development of numerous inflammatory disorders and infections has been linked to altered gut bacterial composition or dysbiosis. Multiple factors contribute to the establishment of the human gut microbiota. For instance, diet is considered as one of the many drivers in shaping the gut microbiota across the lifetime. By contrast, alcohol is one of the many factors that disrupt the proper functioning of the gut, leading to a disruption of the intestinal barrier integrity that increases the permeability of the mucosa, with the final result of a disrupted mucosal immunity. This damage to the permeability of the intestinal membrane allows bacteria and their components to enter the blood tissue, reaching other organs such as the liver or the brain. Although chronic heavy drinking has harmful effects on the immune system cells at the systemic level, this review focuses on the effect produced on gut, brain and liver, because of their significance in the link between alcohol consumption, gut microbiota and the immune system.

7 April 2022 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
LSL. Segovia-Rodríguez
L. Segovia-Rodríguez
Víctor Echeverry-AlzateVíctor Echeverry-Alzate
Víctor Echeverry-Alzate
IRI. Rincón-Pérez
I. Rincón-Pérez
JCJAVIER CALLEJA-CONDE
JAVIER CALLEJA-CONDE
KBK. M. Bühler
K. M. Bühler
JLJosé Antonio López-Moreno
José Antonio López-Moreno
Alcohol is part of the usual diet of millions of individuals worldwide. However, not all individuals who drink alcohol experience the same effects, nor will everyone develop an alcohol use disorder. Here we propose that the intestinal microbiota (IMB) helps explain the different consumption patterns of alcohol among individuals. 507 humans participated in this study and alcohol consumption and IMB composition were analyzed. On the other hand, in 80 adult male Wistar rats, behavioral tests, alcohol intoxication, fecal transplantation, administration of antibiotics and collection of fecal samples were performed. For identification and relative quantification of bacterial taxa was used the bacterial 16 S ribosomal RNA gene. In humans, we found that heavy episodic drinking is associated with a specific stool type phenotype (type 1, according to Bristol Stool Scale;p < 0.05) and with an increase in the abundance ofActinobacteria(p < 0.05). Next, using rats, we demonstrate that the transfer of IMB from alcohol-intoxicated animals causes an increase in voluntary alcohol consumption in transplant-recipient animals (p < 0.001). The relative quantification data indicate that the genusPorphyromonascould be associated with the effect on voluntary alcohol consumption. We also show that gut microbiota depletion by antibiotics administration causes a reduction in alcohol consumption (p < 0.001) and altered the relative abundance of relevant phyla such asFirmicutes,BacteroidetesorCyanobacteria(p < 0.05), among others. Benjamini–Hochberg false discovery rate (FDR) correction was performed for multiple comparisons. These studies reveal some of the consequences of alcohol on the IMB and provide evidence that manipulation of IMB may alter voluntary alcohol consumption.

31 August 2022 in Addiction Biology
Verified
Journal Article
Open access
JCJAVIER CALLEJA-CONDE
JAVIER CALLEJA-CONDE
JMJose A. Morales-García
Jose A. Morales-García
VEVíctor Echeverry‐Alzate
Víctor Echeverry‐Alzate
KBKora Mareen Bühler
Kora Mareen Bühler
EGElena Giné
Elena Giné
JLJosé Antonio López-Moreno
José Antonio López-Moreno
Classic psychedelics refer to substances such as lysergic acid diethylamide (LSD), psilocybin, ayahuasca, and mescaline, which induce altered states of consciousness by acting mainly on 5‐HT2A receptors. Recently, the interest of psychedelics as pharmacological treatment for psychiatric disorders has increased significantly, including their use on problematic use of alcohol. This systematic review is aimed to analyse the last two decades of studies examining the relationship between classic psychedelics and alcohol consumption. We searched PubMed and PsycInfo for human and preclinical studies published between January 2000 to December 2021. The search identified 639 publications. After selection, 27 studies were included. Human studies (n = 20) generally show promising data and seem to indicate that classic psychedelics could help reduce alcohol consumption. Nevertheless, some of these studies present methodological concerns such as low number of participants, lack of control group or difficulty in determining the effect of classic psychedelics in isolation. On the other hand, preclinical studies (n = 7) investigating the effect of these compounds on voluntary alcohol consumption are scarce and show some conflicting data. Among these compounds, psilocybin seems to show the most consistent data indicating that this compound could be a potential candidate to treat alcohol use disorders. In the absence of understanding the biological and/or psychological mechanisms, more studies including methodological quality parameters are needed to finally determine the effects of classic psychedelics on alcohol consumption.